Key Record Dates
ClinicalTrials.gov Identifier: | NCT04521621 |
---|---|
Brief Title: | A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013) |
First Submitted : | August 17, 2020 |
First Submitted that Met QC Criteria : | August 17, 2020 |
First Posted : | August 20, 2020 |
Last Update Submitted that Met QC Criteria : | February 2, 2023 |
Last Update Posted : | February 3, 2023 |